4925
HABA LABORATORIES,INC.
ハーバー研究所
- Industry
- Chemicals
- Market
- Standard
- Accounting standards
- Japanese GAAP
- Consolidation basis
- Consolidated
Key metrics
Revenue(thousand JPY)
Mar 2022
12,908,861
Mar 2023
12,038,052
Mar 2024
12,324,210
Mar 2025
12,061,829
Mar 2026
12,141,299
Operating profit(thousand JPY)
Mar 2022
-316,730
Mar 2023
-609,642
Mar 2024
-187,769
Mar 2025
589,510
Mar 2026
727,365
Operating profit margin(%)
Mar 2022
-2.45
Mar 2023
-5.06
Mar 2024
-1.52
Mar 2025
4.89
Mar 2026
5.99
Profit before tax(thousand JPY)
Mar 2022
-266,955
Mar 2023
-548,664
Mar 2024
-1,843,312
Mar 2025
635,745
Mar 2026
850,049
Profit(thousand JPY)
Mar 2022
-269,030
Mar 2023
-707,865
Mar 2024
-2,118,627
Mar 2025
576,566
Mar 2026
760,360
Total assets(thousand JPY)
Mar 2022
15,685,434
Mar 2023
14,655,217
Mar 2024
12,431,193
Mar 2025
12,344,340
Mar 2026
12,519,336
Cash and cash equivalents(thousand JPY)
Mar 2022
5,651,289
Mar 2023
4,817,842
Mar 2024
3,959,197
Mar 2025
4,743,538
Mar 2026
5,684,507
Cash flows from operating activities(thousand JPY)
Mar 2022
1,714,447
Mar 2023
55,956
Mar 2024
-587,921
Mar 2025
1,621,011
Mar 2026
1,237,182
Cash flows from investing activities(thousand JPY)
Mar 2022
-216,492
Mar 2023
-214,402
Mar 2024
-441,788
Mar 2025
-147,179
Mar 2026
484,538
Cash flows from financing activities(thousand JPY)
Mar 2022
-1,512,977
Mar 2023
-676,322
Mar 2024
171,065
Mar 2025
-689,491
Mar 2026
-780,751
Return on equity(%)
Mar 2022
-2.3
Mar 2023
-6.3
Mar 2024
-22
Mar 2025
6.6
Mar 2026
8.2
Equity ratio(%)
Mar 2022
74.2
Mar 2023
73.5
Mar 2024
68.4
Mar 2025
72.3
Mar 2026
76.2
Earnings per share(JPY per share)
Mar 2022
-71.14
Mar 2023
-187.19
Mar 2024
-560.26
Mar 2025
152.47
Mar 2026
201.07
Net assets per share(JPY per share)
Mar 2022
3,077.51
Mar 2023
2,849.03
Mar 2024
2,249.65
Mar 2025
2,360.75
Mar 2026
2,521.82
Dividend per share(JPY per share)
Mar 2022
40
Mar 2023
40
Mar 2024
40
Mar 2025
40
Mar 2026
40
Payout ratio(%)
Mar 2022
-
Mar 2023
-
Mar 2024
-
Mar 2025
26.23
Mar 2026
19.89
Disclaimer
The financial information and metrics on this page are based on publicly available filings and other public sources. We do not guarantee their accuracy, completeness, or timeliness.
The information on this page is provided for reference purposes only and does not constitute a recommendation to buy or sell any security. Investment decisions should be made at your own responsibility.